Vera Therapeutics IncNASDAQ:VERA
- LAST PRICE44.2000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots32.2300/ 3
- Ask / Lots49.9500/ 1
- Open / Previous Close--- / 44.2000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VERA |
|---|---|---|
| 09:32 ET | 3172 | 43.31 |
| 09:38 ET | 100 | 43.19 |
| 09:39 ET | 900 | 43.99 |
| 09:41 ET | 18858 | 44.46 |
| 09:43 ET | 4589 | 44.12 |
| 09:45 ET | 3375 | 44.32 |
| 09:48 ET | 6147 | 44.92 |
| 09:50 ET | 1300 | 44.79 |
| 09:52 ET | 21110 | 45.31 |
| 09:54 ET | 2134 | 45.37 |
| 09:56 ET | 8373 | 45.245 |
| 09:57 ET | 3204 | 45.575 |
| 10:01 ET | 100 | 45.62 |
| 10:03 ET | 1000 | 45.91 |
| 10:06 ET | 1100 | 45.92 |
| 10:08 ET | 14835 | 46.55 |
| 10:10 ET | 816 | 46.58 |
| 10:12 ET | 2467 | 46.35 |
| 10:14 ET | 7700 | 45.79 |
| 10:15 ET | 4838 | 45.83 |
| 10:17 ET | 784 | 45.7 |
| 10:19 ET | 1900 | 45.57 |
| 10:21 ET | 4644 | 45.31 |
| 10:24 ET | 509 | 45.195 |
| 10:26 ET | 1037 | 45.09 |
| 10:28 ET | 6784 | 45.195 |
| 10:30 ET | 1835 | 45.02 |
| 10:32 ET | 800 | 45.1025 |
| 10:33 ET | 4144 | 45.03 |
| 10:35 ET | 6606 | 45.495 |
| 10:37 ET | 4744 | 45.4 |
| 10:39 ET | 100 | 45.4 |
| 10:44 ET | 1200 | 45.32 |
| 10:46 ET | 650 | 45.37 |
| 10:48 ET | 13054 | 45.3225 |
| 10:50 ET | 2654 | 44.735 |
| 10:51 ET | 7464 | 44.65 |
| 10:53 ET | 2208 | 44.69 |
| 10:55 ET | 9120 | 44.32 |
| 10:57 ET | 1400 | 44.17 |
| 11:00 ET | 6690 | 44.11 |
| 11:02 ET | 3146 | 44 |
| 11:04 ET | 500 | 44.01 |
| 11:06 ET | 3067 | 43.935 |
| 11:08 ET | 1360 | 43.935 |
| 11:09 ET | 2826 | 43.98 |
| 11:11 ET | 1960 | 44.11 |
| 11:13 ET | 100 | 44.075 |
| 11:15 ET | 300 | 44.28 |
| 11:18 ET | 552 | 44.3 |
| 11:20 ET | 300 | 44.33 |
| 11:22 ET | 300 | 44.435 |
| 11:24 ET | 100 | 44.355 |
| 11:26 ET | 700 | 44.37 |
| 11:27 ET | 700 | 44.32 |
| 11:29 ET | 2200 | 44.695 |
| 11:31 ET | 1143 | 44.6 |
| 11:33 ET | 200 | 44.52 |
| 11:40 ET | 1053 | 44.31 |
| 11:42 ET | 600 | 44.275 |
| 11:44 ET | 800 | 44.3 |
| 11:45 ET | 400 | 44.27 |
| 11:47 ET | 13748 | 44.115 |
| 11:51 ET | 29105 | 43.985 |
| 11:54 ET | 400 | 43.86 |
| 11:56 ET | 2145 | 43.52 |
| 11:58 ET | 800 | 43.47 |
| 12:00 ET | 1228 | 43.3 |
| 12:02 ET | 1300 | 43.21 |
| 12:03 ET | 400 | 43.33 |
| 12:05 ET | 4550 | 43.44 |
| 12:07 ET | 2050 | 43.19 |
| 12:09 ET | 300 | 43.19 |
| 12:12 ET | 2932 | 43.455 |
| 12:14 ET | 550 | 43.465 |
| 12:16 ET | 600 | 43.475 |
| 12:18 ET | 1708 | 43.625 |
| 12:20 ET | 1000 | 43.85 |
| 12:21 ET | 100 | 43.8 |
| 12:23 ET | 710 | 43.89 |
| 12:25 ET | 1500 | 43.88 |
| 12:27 ET | 500 | 43.8 |
| 12:30 ET | 2540 | 43.9 |
| 12:32 ET | 5274 | 44.015 |
| 12:34 ET | 3155 | 43.965 |
| 12:36 ET | 3375 | 43.795 |
| 12:38 ET | 500 | 43.805 |
| 12:39 ET | 2200 | 43.72 |
| 12:41 ET | 100 | 43.64 |
| 12:43 ET | 300 | 43.6 |
| 12:48 ET | 1400 | 43.52 |
| 12:54 ET | 11318 | 43.36 |
| 12:56 ET | 3410 | 43.355 |
| 12:57 ET | 1200 | 43.415 |
| 12:59 ET | 1650 | 43.42 |
| 01:01 ET | 1100 | 43.32 |
| 01:03 ET | 400 | 43.16 |
| 01:06 ET | 500 | 43.1 |
| 01:08 ET | 700 | 42.93 |
| 01:12 ET | 600 | 42.93 |
| 01:14 ET | 5345 | 43.355 |
| 01:15 ET | 100 | 43.32 |
| 01:17 ET | 400 | 43.3 |
| 01:19 ET | 100 | 43.35 |
| 01:21 ET | 100 | 43.31 |
| 01:24 ET | 200 | 43.31 |
| 01:26 ET | 4742 | 43.46 |
| 01:28 ET | 300 | 43.48 |
| 01:30 ET | 200 | 43.41 |
| 01:32 ET | 38182 | 43.5 |
| 01:37 ET | 9706 | 43.56 |
| 01:39 ET | 500 | 43.535 |
| 01:42 ET | 11788 | 43.48 |
| 01:44 ET | 2170 | 43.28 |
| 01:46 ET | 800 | 43.14 |
| 01:48 ET | 1300 | 43.115 |
| 01:50 ET | 3462 | 43.17 |
| 01:51 ET | 800 | 43.215 |
| 01:53 ET | 100 | 43.245 |
| 01:55 ET | 500 | 43.28 |
| 01:57 ET | 1300 | 43.23 |
| 02:00 ET | 925 | 43.22 |
| 02:06 ET | 15882 | 42.985 |
| 02:08 ET | 100 | 42.985 |
| 02:09 ET | 707 | 42.9 |
| 02:11 ET | 608 | 42.96 |
| 02:13 ET | 1750 | 42.79 |
| 02:15 ET | 1000 | 42.66 |
| 02:18 ET | 192 | 42.65 |
| 02:22 ET | 700 | 42.615 |
| 02:24 ET | 2747 | 42.85 |
| 02:26 ET | 950 | 42.855 |
| 02:27 ET | 6339 | 43.005 |
| 02:29 ET | 500 | 43 |
| 02:31 ET | 639 | 43.005 |
| 02:33 ET | 800 | 43.01 |
| 02:36 ET | 2099 | 42.925 |
| 02:38 ET | 600 | 42.96 |
| 02:40 ET | 3431 | 42.915 |
| 02:42 ET | 2910 | 42.965 |
| 02:44 ET | 900 | 43.02 |
| 02:45 ET | 3397 | 43.06 |
| 02:47 ET | 11600 | 43.07 |
| 02:49 ET | 1150 | 42.995 |
| 02:51 ET | 665 | 42.72 |
| 02:54 ET | 8140 | 42.75 |
| 02:56 ET | 1350 | 42.84 |
| 02:58 ET | 200 | 42.81 |
| 03:00 ET | 1500 | 42.77 |
| 03:02 ET | 2850 | 42.59 |
| 03:03 ET | 300 | 42.645 |
| 03:05 ET | 1664 | 42.66 |
| 03:07 ET | 1100 | 42.565 |
| 03:09 ET | 200 | 42.65 |
| 03:12 ET | 3650 | 42.65 |
| 03:14 ET | 1800 | 42.48 |
| 03:16 ET | 1247 | 42.35 |
| 03:18 ET | 13658 | 42.5 |
| 03:20 ET | 8856 | 42.72 |
| 03:21 ET | 3940 | 42.94 |
| 03:23 ET | 7270 | 43.21 |
| 03:25 ET | 13616 | 43.795 |
| 03:27 ET | 1995 | 43.905 |
| 03:30 ET | 16309 | 44.19 |
| 03:32 ET | 10076 | 44.43 |
| 03:34 ET | 7266 | 44.305 |
| 03:36 ET | 3600 | 44.595 |
| 03:38 ET | 8477 | 44.52 |
| 03:39 ET | 1135 | 44.52 |
| 03:41 ET | 6130 | 44.505 |
| 03:43 ET | 6420 | 44.68 |
| 03:45 ET | 5744 | 44.93 |
| 03:48 ET | 10553 | 44.575 |
| 03:50 ET | 3944 | 44.49 |
| 03:52 ET | 6680 | 44.55 |
| 03:54 ET | 7422 | 44.515 |
| 03:56 ET | 14565 | 44.4201 |
| 03:57 ET | 13703 | 44.45 |
| 03:59 ET | 83459 | 44.2 |
Sep 23, 2024
DJ Vera Therapeutics Price Target Maintained With a $107.00/Share by Cantor Fitzgerald, from 8:56AM ET on Monday Sep 23, 2024 by Dow Jones
8:56AM ET on Monday Sep 23, 2024 by Dow Jones
Sep 16, 2024
DJ Vera Therapeutics Price Target Maintained With a $107.00/Share by Cantor Fitzgerald, from 1:15PM ET on Monday Sep 16, 2024 by Dow Jones
1:15PM ET on Monday Sep 16, 2024 by Dow JonesVera Therapeutics to Host In-Person R&D Day in New York to Discuss Potential Indication Expansion for Atacicept on October 2, 2024, from 8:00AM ET on Monday Sep 16, 2024 by Dow Jones
8:00AM ET on Monday Sep 16, 2024 by Dow Jones
Sep 12, 2024
Vera Therapeutics Completes Enrollment for Primary Endpoint in Pivotal Phase 3 ORIGIN 3 Trial of Atacicept in IgAN, from 8:00AM ET on Thursday Sep 12, 2024 by Dow Jones
8:00AM ET on Thursday Sep 12, 2024 by Dow Jones
Sep 10, 2024
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:05PM ET on Tuesday Sep 10, 2024 by Dow Jones
4:05PM ET on Tuesday Sep 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vera Therapeutics Inc | 2.4B | -20.1x | --- |
Edgewise Therapeutics Inc | 2.5B | -17.4x | --- |
SpringWorks Therapeutics Inc | 2.4B | -7.2x | --- |
Verona Pharma PLC | 2.3B | -18.5x | --- |
Structure Therapeutics Inc | 2.5B | -19.6x | --- |
Janux Therapeutics Inc | 2.4B | -49.6x | --- |
Company Information
Vera Therapeutics, Inc. is a late-stage biotechnology company. The Company is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Its product candidate, atacicept, is a self-administered fusion protein that blocks both a B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL) which stimulates B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. The Company is also engaged in developing MAU868, a monoclonal antibody designed to neutralize infection with BK Virus, a polyomavirus that can have devastating consequences in certain settings such as kidney transplants. The Company is conducting a randomized, double-blind, placebo-controlled Phase 3 clinical trial in IgAN, which it refers to as ORIGIN 3, and completing the open label extension of its Phase 2b clinical trial in IgAN, which it refers to as ORIGIN 2b.
Contact Information
- Headquarters
- 8000 Marina Boulevard,, Suite 120BRISBANE, CA, United States 94005
- Phone
- 650-770-0077
- Fax
- 302-655-5049
Executives
- Independent Non-Executive Chairman of the Board
- Michael Morrissey
- President, Chief Executive Officer, Founder, Director
- Marshall Fordyce
- Chief Financial Officer
- Sean Grant
- Chief Operating Officer
- David Johnson
- Chief Medical Officer
- Robert Brenner
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.4B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 54.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.00 |
EPS | $-2.20 |
Book Value | $2.29 |
P/E Ratio | -20.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
